Real‐World Adherence in Patients With Metastatic Colorectal Cancer Treated With Trifluridine Plus Tipiracil or Regorafenib
Oncologist - United States
doi 10.1634/theoncologist.2019-0240
Full Text
Open PDFAbstract
Available in full text
Date
October 7, 2019
Authors
Publisher
Alphamed Press